| 1.07 Data as of 3:38pm ET | Today’s Change | 0.78 Today|||52-Week Range 27.74 | -94.37% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP -- |
Affymax, Inc. 4001 Miranda Avenue Palo Alto California 94304 |

| Richard M. Brenner | Chief Executive Officer & Director |
| Mark G. Thompson, MBA | Chief Financial Officer |
| Andrew T. Blair, MD | Vice President-Medical Affairs |
| Anne-Marie Duliege, MD | Chief Medical Officer |
| Carol A. Francisco, PhD | Vice President-Biostatistics & Data Management |